Azizi, Michel <br/><br/>
Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jan 2006 
 - 49-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/j.clpt.2005.09.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aldosterone--urine<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacokinetics<br/>Atrial Natriuretic Factor--urine<br/>Biotransformation<br/>Biphenyl Compounds--pharmacology<br/>Cross-Over Studies<br/>Cyclic GMP--urine<br/>Dose-Response Relationship, Drug<br/>Heterocyclic Compounds, 3-Ring--pharmacokinetics<br/>Humans<br/>Irbesartan<br/>Male<br/>Natriuresis--drug effects<br/>Oligopeptides--urine<br/>Peptidyl-Dipeptidase A--blood<br/>Protease Inhibitors--pharmacokinetics<br/>Ramipril--pharmacology<br/>Renin--blood<br/>Renin-Angiotensin System--drug effects<br/>Single-Blind Method<br/>Tetrazoles--pharmacology